There is obviously something unbalanced in the pharma business, and I think it is one of the corner cases where unbridled capitalism fails - perhaps because it is a need, not a want, so it is not discretionary spending.<p>My instinct is that pharma development should be carried out by universities (the state), so it&#x27;s benefits can be shared with all citizens.